Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 575,000 PLRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 575,000 | n/a |
| Apr 28, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 5,500 | $20.8K |
| Mar 26, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 5,500 | $20.8K |
| Mar 6, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 200 | $757.96 |
| Feb 4, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 100,000 | n/a |
| Dec 29, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 19,789 | $75.0K |
| Nov 25, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 5,500 | $20.8K |
| Oct 10, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 22,000 | $83.4K |